Ashton Tweed Connection Vol. 2 No. 4

Share

Featuring CEO Interview with Dr. Warren Cooper, President, Coalescence Inc.

Ashton Tweed logo

Facebook Twitter LinkedIn YouTube Google

Ashton Tweed Connection

Volume 2, Number 4

Whether you are or you require executive or management talent — interim, permanent, or interim to hire — Ashton Tweed can meet your specialized retained search and executive search needs.

CEO Leadership Series: Warren Cooper
Check out our latest CEO Interview with Dr. Warren Cooper in its new location! Mr. Cooper draws on decades of experience as a CEO to discuss the importance of building a strong board of directors.
Read More: Medical Device Companies Grow by Sharing

READ MORE

Coaching New CEOs to Best Build Business
Interim VP of Clinical Development a Permanent Success
A privately held biotechnology company located in New Jersey needed to hire a new Vice President of Clinical Development. The company decided that finding a replacement whose skills would uniquely apply to their technology would be best handled by a professional retained search firm…
Read more: Most Common Mistakes of Start-Ups

Read more

13 Vital Traits of Successful Entrepreneurs
3 Ways Interim Talent Can Turn Into A Permanent Asset
Interim talent can be brought on board under many different circumstances. Progress and change are a natural part of the life sciences industry, and that applies to life science staff as well. The ups and downs of business require different talent to be utilized at different times in the process.
Read more: VP of Finance Gets Hands-On

READ MORE

Stay Connected: Special Targeted News

Go beyond the news… Get more focused information about your industry and hiring trends. Click now to enhance your subscription.

Stay Connected: Special Targeted News

The top 15 pharma companies by 2014 revenue
What’s in a (drug) name?
It’s been a few weeks since FiercePharmaMarketing‘s 2015 Drug Name Tournament came to a close. Now they’ve interviewed the winner, BioMarin’s Vimizin and asked where the name came from and what made it so successful.
Read more: 7 Trends Driving Life Sciences in 2015

Read more

Outlook for the medical device industry in 2015
Top 10 U.S. Biotech Companies
Biotechnology firms are a growing sector of the pharma industry. As of January 2015, Forbes compiled a list of the United States’ ten biggest biotech companies according to their market value.
Read more: 2015: The Antibiotics Renaissance?

Read more

A Wild Ride: Biotech Financial and M&A Trends 2014
Seeking Analytical Chemists
Analytical chemists play a critical role in many industries, and those with interdisciplinary backgrounds are in even greater demand. The demand is so great that some worry whether there will be enough analytical chemists to keep up with each industry’s growing needs.
Read more: FDA launches New Office

Read more

Top 10 U.S. Biopharma Clusters
Biotech’s Not Lost in Space
Detailed in this article are the first 5 experiments featured in GEN’s list of recent studies carried out in space for for the purpose of human health or drug R&D. This is just a glimpse of the variety of life sciences research carried out in space in recent years…
Read More: New "Era Of Interdependence"

Read more

Maximizing Pharma Partnerships: Dos And Don'ts From Industry Experts

BIO International Convention 2015: Résumé Builder Workshop
We are honored that the 2015 BIO International Convention will be hosted in Philadelphia this year from June 15-18th! Ashton Tweed’s Jordan Warshafsky, who served on the Program Committee to help create a top-quality educational program, will be presenting this workshop with Joulé Staffing Solutions.
Save the date: June 18, 2015 at 2:00 & 3:00PM!
Read more: Why is Google Making Human Skin?

READ MORE

Honey, I shrunk the drugs
While nanomedicine is on the small side, it promises to be big business. Estimates suggest the market could grow to $130.9 billion by next year. One of the most recent developments are targeted nanomedicines, which specifically target cancer cells and HIV for example, but leave healthy cells intact.
Read More: BMS COO to take over as CEO

READ MORE

The Retirement Debate

Stay at the bench, or make way for the next generation? The NIH has noted a decline in the proportion of grants going to younger researches, and a rise in those going to researchers 66 and over. This raises the concern that the availability of grants and jobs for young scientists is limited.
Read more: Burrill's Annual Predictions for Biotech

READ MORE

Share

Comments are closed.